Adam Rich1, Yingmin Liu2, Lee C. Potter3, Ning Jin4, Orlando P. Simonetti2,5, and Rizwan Ahmad1,2
1Biomedical Engineering, The Ohio State University, Columbus, OH, United States, 2Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, United States, 3Electrical Engineering, The Ohio State University, Columbus, OH, United States, 4Siemens Healthcare, Columbus, OH, United States, 5Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States
Synopsis
MRI-based 4D flow imaging is capable of yielding spatially
and temporally resolved mapping of the blood velocity vector. Long acquisition times
associated with 4D flow imaging limits its clinical utility. In this work, we
apply a recently proposed technique, called ReVEAL4D, to perform 4D flow
imaging in 19 patients with aortic valve stenosis. The peak velocity obtained
using ReVEAL4D shows good agreement with both transthoracic echocardiography (TTE)
and traditional GRAPPA-based 4D flow imaging.
Introduction
The clinical gold standard for measuring the severity of aortic
valve stenosis (AVS) is TTE, which offers a fast and inexpensive exam that can
quantify key biomarkers. However, TTE is
sensitive to direction and misalignment of the beam with the aortic jet can
cause underestimation of the peak velocity. In addition, certain patient anatomies prohibit
proper beam alignment and necessitate transesophageal echocardiography, which
is an invasive procedure. TTE has been
shown to be suboptimal in 30% of patients1. Phase-contrast MRI (PC-MRI)
based 4D flow measurements do not suffer from the misalignment issues of
TTE. However, conventional 4D flow requires
long acquisition time, exceeding 10 or even 20 minutes, limiting its clinical
applications. The recently proposed ReVEAL4D2 demonstrated the feasibility
of acquiring 4D flow data within a single breath-hold for peak velocity
estimation at the aortic valve. In this work, we compare the efficacy of single
breath-hold 4D flow imaging prototype against TTE and navigator
respiratory-gated free-breathing 4D flow imaging to assess the severity of AVS in
nineteen patients. Methods
For this study, 19 patients with moderate to severe AVS, as
measured by TTE, were recruited to undergo a 4D flow MRI scan within two months
of the TTE exam. TTE measured the
maximum velocity above the aortic valve (Vmax). All MRI exams were performed on 1.5T clinical
scanner (MAGNETOM Avanto, Siemens Healthcare, Germany). The MRI protocol
included two 4D flow scans, each covering a thin (48 mm) slab encompassing the
aortic valve. First, a respiratory
navigator-gated acquisition accelerated with rate 3 GRAPPA was performed with an
average scan time of 14 min . Second, a single breath-hold (24 heartbeats) 4D
flow scan at R=21-27 was performed. The
single breath-hold scan was reconstructed using ReVEAL4D2 offline with
custom Matlab (Mathworks, Natick Massachusetts) code. Vmax was
calculated from the PC-MRI scans by contouring the four imaging planes above
the aortic valve. To extract Vmax,
the maximum velocity within the region of interest over imaging plane and all cardiac
phases was found for each patient. For single breath-hold scans, relevant scan
parameters were as follows:
TR 4.4 ms, TE
2.18 ms, TRES 36ms, flip angle 10°, FOV 430x346-280x217 mm, matrix size
[144,108,12]-[144,84,12] with 50% oversampling, in plane resolution <= 3x3
mm2, and slice thickness 6 mm. For respiratory navigator-gated GRAPPA
the relevant scan parameters are as follows: TR 4.4 ms,
TE 2.18 ms, TRES 36ms, flip angle 10°, FOV 217x310-343x490
mm, matrix size [160,120,12], in
plane resolution <=3mm, and slice thickness 6 mm. Bland-Altman, Pearson
correlation, and linear regression where performed to compare the Vmax
of ReVEAL4D to TTE, ReVEAL4D to GRAPPA, and GRAPPA to TTE. Results
Statistics comparing ReVEAL4D and TTE are shown in Figure
1. Vmax estimated using
ReVEAL4D is in good agreement (r = 0.643) with TTE. In Figure 2, the statistics comparing Vmax
estimated from ReVEAL4D and GRAPPA are shown.
ReVEAL4D shows stronger agreement with GRAPPA (r=0.682) than with
TTE. Comparison between TTE and GRAPPA
is shown in Figure 3. GRAPPA and TTE
show the strongest agreement (r=0.843). However,
GRAPPA consistently overestimates the peak velocity and takes 20-30 times
longer to acquire. Representative
magnitude and velocity maps from GRAPPA and ReVEAL4D reconstructions for a
single slice are shown in Figure 4. Discussion and Conclusion
We have demonstrated the feasibility of quantifying Vmax
in a single breath hold using 4D flow imaging. Future work will explore additional AVS biomarkers calculated from single breath-hold acquisitions, such as
effective valve area and peak pressure gradient across the aortic valve.Acknowledgements
This work was funded in part by NIH projects R21EB021655 and R01HL135489. The Tesla K40 used for this research was donated by the NVIDIA Corporation. RA and OPS receive research support from Siemens Healthineers. OPS receives funding support from The Robert F. Wolfe and Edgar T. Wolfe Foundation.References
[1] Senior R, Dwivedi G, Hayat S, Lim TK. Clinical benefits
of contrast-enhanced echocardiography during rest and stress examinations. Eur
J Echocardiogr. 2005;6 Suppl 2:S6–13.
[2] Rich A., Potter L. C., Jin N., et al. A Bayesian
approach for 4D flow imaging of aortic valve in a single breathâhold. Magn
Reson Med. 2018;00:1–14. https://doi.org/10.1002/mrm.27386